{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T16:55:55Z","timestamp":1795020955225,"version":"4.10.1"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurology and Neurosurgery"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.clineuro.2021.106500","type":"journal-article","created":{"date-parts":[[2021,1,18]],"date-time":"2021-01-18T20:29:31Z","timestamp":1611001771000},"page":"106500","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Oxidative stress activity of fingolimod in multiple sclerosis"],"prefix":"10.1016","volume":"202","author":[{"given":"Recep","family":"Yevgi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Recep","family":"Demir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clineuro.2021.106500_bib0005","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/S0140-6736(08)61620-7","article-title":"Multiple sclerosis","volume":"372","author":"Compston","year":"2008","journal-title":"Lancet"},{"issue":"Pt 7","key":"10.1016\/j.clineuro.2021.106500_bib0010","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1093\/brain\/awr128","article-title":"Oxidative damage in multiple sclerosis lesions","volume":"134","author":"Haider","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.clineuro.2021.106500_bib0015","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jns.2008.06.029","article-title":"Neurodegeneration in multiple sclerosis: the role of oxidative stress and excitotoxicity","volume":"274","author":"Gonsette","year":"2008","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.clineuro.2021.106500_bib0020","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s00415-004-0348-9","article-title":"The role of oxidative stress in the pathogenesis of multiple sclerosis: the need for effective antioxidant therapy","volume":"251","author":"Gilgun-Sherki","year":"2004","journal-title":"J. Neurol."},{"key":"10.1016\/j.clineuro.2021.106500_bib0025","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1155\/2009\/325847","article-title":"Oxidative stress is increased in serum from Mexican patients with relapsing-remitting multiple sclerosis","volume":"26","author":"Ortiz","year":"2009","journal-title":"Dis. Markers"},{"key":"10.1016\/j.clineuro.2021.106500_bib0030","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1468-1331.2007.01739.x","article-title":"Plasma lipid peroxidation and progression of disability in multiple sclerosis","volume":"14","author":"Koch","year":"2007","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.clineuro.2021.106500_bib0035","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1080\/10284150290029205","article-title":"Serum levels of antioxidant vitamins and lipid peroxidation in multiple sclerosis","volume":"5","author":"Besler","year":"2002","journal-title":"Nutr. Neurosci."},{"key":"10.1016\/j.clineuro.2021.106500_bib0040","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/1028415031000115945","article-title":"Lipoprotein oxidation, plasma total antioxidant capacity and homocysteine level in patients with multiple sclerosis","volume":"6","author":"Besler","year":"2003","journal-title":"Nutr. Neurosci."},{"issue":"4","key":"10.1016\/j.clineuro.2021.106500_bib0045","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s00415-005-0037-3","article-title":"Oxidative stress in serum and peripheral blood leukocytes in patients with different disease courses of multiple sclerosis","volume":"253","author":"Koch","year":"2006","journal-title":"J. Neurol."},{"issue":"3","key":"10.1016\/j.clineuro.2021.106500_bib0050","first-page":"112","article-title":"Oxidative stress in patients with multiple sclerosis","volume":"71","author":"Syburra","year":"1999","journal-title":"Ukr. Biokhim. Zh."},{"key":"10.1016\/j.clineuro.2021.106500_bib0055","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0009-9120(93)90111-I","article-title":"Human disease, free radicals, and the oxidant \/ antioxidant balance","volume":"26","author":"McCord","year":"1993","journal-title":"Clin. Biochem."},{"issue":"8","key":"10.1016\/j.clineuro.2021.106500_bib0060","doi-asserted-by":"crossref","first-page":"889","DOI":"10.2217\/bmm-2016-0097","article-title":"Oxidative stress-related biomarkers in multiple sclerosis: a review","volume":"10","author":"Ibitoye","year":"2016","journal-title":"Biomark. Med."},{"issue":"4","key":"10.1016\/j.clineuro.2021.106500_bib0065","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1177\/135245859900500409","article-title":"The Multiple Sclerosis Functional Composite Measure (MSFC): an integrated approach to MS clinical outcome assessment. National MS Society Clinical Outcomes Assessment Task Force","volume":"5","author":"Fischer","year":"1999","journal-title":"Mult. Scler."},{"issue":"23","key":"10.1016\/j.clineuro.2021.106500_bib0070","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1212\/WNL.0b013e3181e24136","article-title":"Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypes","volume":"74","author":"De Stefano","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.clineuro.2021.106500_bib0075","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/nrd3248","article-title":"Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis","volume":"9","author":"Brinkmann","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.clineuro.2021.106500_bib0080","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jneuroim.2004.04.015","article-title":"Sphingosine 1-phosphate receptor agonists attenuate relapsing-remitting experimental autoimmune encephalitis in SJL mice","volume":"153","author":"Webb","year":"2004","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.clineuro.2021.106500_bib0085","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1126\/science.1070238","article-title":"Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists","volume":"296","author":"Mandala","year":"2002","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.clineuro.2021.106500_bib0090","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jss.2015.03.014","article-title":"FTY720 mitigates torsion\/detorsion-induced testicular injury in rats","volume":"196","author":"Shih","year":"2015","journal-title":"J. Surg. Res."},{"issue":"12","key":"10.1016\/j.clineuro.2021.106500_bib0095","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.clinbiochem.2005.08.008","article-title":"A new automated colorimetric method for measuring total oxidant status","volume":"38","author":"Erel","year":"2005","journal-title":"Clin. Biochem."},{"issue":"4","key":"10.1016\/j.clineuro.2021.106500_bib0100","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.clinbiochem.2003.11.015","article-title":"A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation","volume":"37","author":"Erel","year":"2004","journal-title":"Clin. Biochem."},{"issue":"5","key":"10.1016\/j.clineuro.2021.106500_bib0105","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1185\/03007995.2012.681637","article-title":"Annualized relapse rate of first-line treatments for multiple sclerosis: a meta-analysis, including indirect comparisons versus fingolimod","volume":"28","author":"Roskell","year":"2012","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.clineuro.2021.106500_bib0110","doi-asserted-by":"crossref","first-page":"58","DOI":"10.5114\/fn.2013.34197","article-title":"Evaluation of oxidative and nitrosative stress in relapsing remitting multiple sclerosis: effect of corticosteroid therapy","volume":"51","author":"Seven","year":"2013","journal-title":"Folia Neuropathol."},{"key":"10.1016\/j.clineuro.2021.106500_bib0115","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1177\/135245850000600603","article-title":"Increase in serum levels of uric acid, an endogenous antioxidant, under treatment with glatiramer acetate for multiple sclerosis","volume":"6","author":"Constantinescu","year":"2000","journal-title":"Mult. Scler."},{"key":"10.1016\/j.clineuro.2021.106500_bib0120","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/S1734-1140(13)71039-9","article-title":"Effect of natalizumab on oxidative damage biomarkers in relapsing-remitting multiple sclerosis","volume":"65","author":"Tasset","year":"2013","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.clineuro.2021.106500_bib0125","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jns.2012.07.045","article-title":"Oxidative stress in multiple sclerosis patients in clinical remission: association with the expanded disability status scale","volume":"321","author":"Oliveira","year":"2012","journal-title":"Journal of the Neurolocigal science."},{"issue":"10","key":"10.1016\/j.clineuro.2021.106500_bib0130","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1080\/10715762.2018.1535176","article-title":"Are antioxidant parameters in serum altered in patients with relapsing-remitting multiple sclerosis treated with II-line immunomodulatory therapy?","volume":"52","author":"Adamczyk","year":"2018","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.clineuro.2021.106500_bib0135","doi-asserted-by":"crossref","first-page":"9625806","DOI":"10.1155\/2017\/9625806","article-title":"The evaluation of oxidative stress parameters in serum patients with relapsing-remitting multiple sclerosis treated with II-Line immunomodulatory therapy","volume":"2017","author":"Adamczyk","year":"2017","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.clineuro.2021.106500_bib0140","doi-asserted-by":"crossref","first-page":"708659","DOI":"10.1155\/2013\/708659","article-title":"Immunology and oxidative stress in multiple sclerosis: clinical and basic approach","volume":"2013","author":"Ortiz","year":"2013","journal-title":"Clin. Dev. Immunol."},{"issue":"5","key":"10.1016\/j.clineuro.2021.106500_bib0145","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/ana.22426","article-title":"Mechanisms of fingolimod\u2019s efficacy and adverse effects in multiple sclerosis","volume":"69","author":"Cohen","year":"2011","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.clineuro.2021.106500_bib0150","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1080\/13510002.2020.1795587","article-title":"High day-to-day and diurnal variability of oxidative stress and inflammation biomarkers in people with type 2 diabetes mellitus and healthy individuals","volume":"25","author":"Mallard","year":"2020","journal-title":"Redox Rep."},{"issue":"4","key":"10.1016\/j.clineuro.2021.106500_bib0155","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1080\/13547500600799748","article-title":"Reliability of biomarkers of iron status, blood lipids, oxidative stress, vitamin D, C-reactive protein and fructosamine in two Dutch cohorts","volume":"11","author":"Al-Delaimy","year":"2006","journal-title":"Biomarkers."},{"key":"10.1016\/j.clineuro.2021.106500_bib0160","doi-asserted-by":"crossref","first-page":"2697464","DOI":"10.1155\/2017\/2697464","article-title":"Within-subject reliability and between-subject variability of oxidative stress markers in saliva of healthy subjects: a longitudinal pilot study","volume":"2017","author":"Alajbeg","year":"2017","journal-title":"Dis. Markers"}],"container-title":["Clinical Neurology and Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846721000275?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846721000275?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T14:35:24Z","timestamp":1759588524000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303846721000275"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":32,"alternative-id":["S0303846721000275"],"URL":"https:\/\/doi.org\/10.1016\/j.clineuro.2021.106500","relation":{},"ISSN":["0303-8467"],"issn-type":[{"value":"0303-8467","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oxidative stress activity of fingolimod in multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurology and Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clineuro.2021.106500","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106500"}}